Stock Evaluator: Redcare Pharmacy NV (SAEYY)
Redcare Pharmacy NV SAEYY
$7.00
0.00
0.00%
August 18, 2026 12:40:55 PM
EST
Volume: 0
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Staples | Consumer Staples Distribution & Retail |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands.
Financial Summary
| Share Statistics | SAEYY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,487.6 | $5,401.4 | 50% |
|
| Shares Out (Mil) | 23.5 | 97.1 | 33% |
|
| Institutional Ownership | 34.0% | 50.0% | 14% |
|
| Float (Mil) | 14.6 | 191.6 | 24% |
|
| Beta | 1.44 | 0.61 | 82% |
|
| Avg Daily Volume (000s) | 2 | 124 | 9% |
|
| Price Change (52-week) |
60.9% | 77.8% | 82% |
|
| Growth | SAEYY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 23.9% | 6.4% | 85% |
|
| Net Income (5yr) | (16.7%) | 10.7% | 24% |
|
| EPS (5yr) | (9.1%) | 12.4% | 22 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (16.1%) | (16.6%) | 45% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | SAEYY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,676 | $9,101 | 70% |
|
| Net Income (TTM) (Mil) | ($48) | $209 | 16% |
|
| EPS (TTM) | ($2.386) | $0.400 | 13% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | $554 | 23% |
|
| Net Cash Flow (TTM) (Mil) | ($22) | $4 | 25% |
|
| Long-Term Debt (Q1) (Mil) | $378 | $990 | 56% |
|
| Enterprise Value (Q1) (Mil) | $1,812 | $6,727 | 48% |
|
| Valuation | SAEYY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.23 | na |
|
| P/E | na | 22.0 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | SAEYY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 21.6% | 24.1% | 23% |
|
| Net Margin | (1.3%) | 2.1% | 30% |
|
| ROA | (3.5%) | 4.5% | 32% |
|
| ROE | (8.6%) | 12.7% | 28% |
|
| Liabilities to Assets | 58.9% | 68.1% | 52% |
|
| F-Score | na | 5 | na |
|
Redcare Pharmacy NV did not pass any screens on 8/21/2026.
